| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 353,00 | 360,00 | 13:04 |
Public release of Virbac Consolidated Accounts at 31 December 2023.
The Group released its 2023 Consolidated Accounts. The document is available on the corporate website, at corporate.virbac.com, under "Investors", "Financial Reports".
Attachment
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 24.04. | Virbac: Public release of Virbac Annual Report at 31 December 2023 (ESEF format) | ||
| 16.04. | VIRBAC: Building on the momentum of the second half of 2023, strong first-quarter revenue growth of +10.8% at constant exchange rates | KEY FIGURESRevenue1st quarter 2024 €345.7MGrowth at constant exchange rates and scope1 +9.7% of which companion animals +16.2%farm animals +1.2%Growth at constant exchange rates +10.8%... ► Artikel lesen | |
| 09.04. | Virbac: Declaration of the number of shares and voting rights 03/2024 | ||
| 02.04. | Virbac acquired Sasaeah, a leading animal health player in Japan | On April 1, we successfully completed the acquisition of Sasaeah. This strategic acquisition brings Virbac a leadership position in the farm animal vaccines market in Japan, notably in the cattle segment... ► Artikel lesen | |
| 20.03. | Virbac slips, FY results in line with expectations |
